| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/18/2000 | US6090600 Valyl tRNA synthetase from Staphylococcus aureus |
| 07/18/2000 | US6090587 Prokaryotic expression of MHC proteins |
| 07/18/2000 | US6090585 Dna sequence; for treatment or prevention of connective tissue diseases related to metalloproteinases such as periodontal disease, corneal and skin ulcers, and rheumatoid arthritis; antitumor/anticarcinogenic/antimetastasis agents |
| 07/18/2000 | US6090583 Expression system in compatible host cell of a polynucleotide which produces a metalloprotease; diagnosis and treatment of asthma, disorders of leukotriene metabolism; anticarcinogenic agents; antiinflammatory/antidiabetic/antiarthritic agents |
| 07/18/2000 | US6090580 Interferon responsive transcript (IRT-1) |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090577 Disease associated acidic protein |
| 07/18/2000 | US6090565 Measuring level of at least one glucosylceramide in said test cell and comparing to level in non-drug resistant cell; higher level indicates resistance |
| 07/18/2000 | US6090564 Amino acid sequence of human small nuclear ribonucleoprotein protein; for diagnosis, prevention and treatment of systemic lupus erythematosus |
| 07/18/2000 | US6090561 NF-AT-interacting protein NIP45 and methods of use therefor |
| 07/18/2000 | US6090560 Screening a compound for binding to excitatory amino acid transporter in cells by transforming host cell with recombinant expression construct expressing human transporter and assaying to determine binding |
| 07/18/2000 | US6090544 Screening for compounds capable of activating osteogenic protein-1-responsive transcription activating element by transforming cell with dna of element linked to reporter gene, exposing cell to compound, determining gene expression |
| 07/18/2000 | US6090542 Inhibiting the activity of nf-kb, a transcription factor, by treating the cells with a substance which specifically inhibits the proteolytic degradation of ikb-alpha |
| 07/18/2000 | US6090407 Administering anticancer drug to respiratory system |
| 07/18/2000 | US6090390 Diagnostic test for equine arteritis virus mediated disease |
| 07/18/2000 | US6090388 Peptide composition for prevention and treatment of HIV infection and immune disorders |
| 07/18/2000 | US6090384 Antiallergic compostion |
| 07/18/2000 | US6090383 Monoclonal antibodies to transforming growth factor-β and methods of use |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | US6090381 Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope |
| 07/18/2000 | US6090379 Stable pre-occluded virus particle for use in recombinant protein production and pesticides |
| 07/18/2000 | US6090378 Cells which are allogeneic or xenogeneic for mammal, comprise a gene encoding interleukin-2, and a retrovirus which infects dividing cells of mammal and comprises a gene encoding thymidine kinase; antitumor agent |
| 07/18/2000 | US6090377 Monocyte activating cytokine |
| 07/18/2000 | US6090367 Adminitering to a mammal a synthetic or natural cd36 peptide containing 6 amino acids to inhibit the activation of latent-transorming growth factor-beta 1 in mammal which is responsible for inflammatory or fibrotic diseases |
| 07/18/2000 | US6090365 Radioimmunotherapy of lymphoma using anti-CD20 antibodies |
| 07/18/2000 | CA2175797C Human kunitz-type protease inhibitors |
| 07/18/2000 | CA2162689C Immunotoxins comprising gelonin and an antibody |
| 07/18/2000 | CA2132933C Soft gelatin capsule manufacture |
| 07/18/2000 | CA2108777C Modified plant viruses as vectors |
| 07/18/2000 | CA2093927C Ligand-mediated immunofunctional hormone binding protein assay method |
| 07/18/2000 | CA2087087C Molecules for iontophoretic delivery |
| 07/18/2000 | CA2017315C Interleukin i inhibitor |
| 07/18/2000 | CA2004332C Inhibition of cell adhesion |
| 07/18/2000 | CA1341055C Transfectant cell lines which express the major human rhinovirus receptor |
| 07/18/2000 | CA1341053C Polypeptide and protein derivatives and process for their preparation |
| 07/13/2000 | WO2000040740A2 Gene therapy to promote angiogenesis |
| 07/13/2000 | WO2000040737A1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 07/13/2000 | WO2000040734A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040728A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | WO2000040726A1 Human chemokine beta-10 mutant polypeptides |
| 07/13/2000 | WO2000040725A1 Screening method |
| 07/13/2000 | WO2000040724A1 Human seven-transmembrane receptors |
| 07/13/2000 | WO2000040723A2 Methods and products for delivering nucleic acids |
| 07/13/2000 | WO2000040722A2 Insulin-synthesis genes |
| 07/13/2000 | WO2000040719A2 Tissue repair protein involved in orofacial clefting and uses thereof |
| 07/13/2000 | WO2000040718A2 MUTANTS OF GNRPs AND VECTORS SUITABLE FOR THEIR EXPRESSION |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040713A1 Method of preventing immune and hypersensitivity reactions |
| 07/13/2000 | WO2000040705A2 Human desaturase gene and uses thereof |
| 07/13/2000 | WO2000040693A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 07/13/2000 | WO2000040616A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/13/2000 | WO2000040615A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 07/13/2000 | WO2000040614A2 Characterization of the soc/crac calcium channel protein family |
| 07/13/2000 | WO2000040613A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040612A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040611A1 Slimming cosmetic compositions |
| 07/13/2000 | WO2000040610A1 Process for producing activated protein |
| 07/13/2000 | WO2000040609A1 Novel protein |
| 07/13/2000 | WO2000040608A1 Proteins from rana pipiens and their use in the treatment of tumors |
| 07/13/2000 | WO2000040606A2 Modulation of hiv replication using sam68 |
| 07/13/2000 | WO2000040605A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 07/13/2000 | WO2000040600A1 Selective inhibitors of mmp-12 |
| 07/13/2000 | WO2000040599A1 Polyol compounds, their production and use |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040594A1 AcpS |
| 07/13/2000 | WO2000040578A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040564A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040563A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/13/2000 | WO2000040548A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/13/2000 | WO2000040273A2 Treatment of viral diseases using an interferon omega expressing polynucleotide |
| 07/13/2000 | WO2000040272A2 P450 / acetaminophen gdept for cancer treatment |
| 07/13/2000 | WO2000040271A2 P450 / acetaminophen gdept for cancer treatment |
| 07/13/2000 | WO2000040269A2 Pharmaceutical compositions for treatment of diseased tissues |
| 07/13/2000 | WO2000040268A1 Antitumor agents |
| 07/13/2000 | WO2000040265A1 Potentiation of anti-cd38-immunotoxin cytotoxicity |
| 07/13/2000 | WO2000040264A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| 07/13/2000 | WO2000040263A1 Production and use of a composition containing ivig for treating diseases that are characterized by elevated extracellular fasl titers |
| 07/13/2000 | WO2000040260A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/13/2000 | WO2000040259A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 07/13/2000 | WO2000040253A1 Synthetic, highly charged molecules and uses thereof |
| 07/13/2000 | WO2000040241A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 07/13/2000 | WO2000040240A1 Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors |
| 07/13/2000 | WO2000040229A2 Synergistic tumorcidal response induced by histamine |
| 07/13/2000 | WO2000040227A2 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 07/13/2000 | WO2000040226A2 Method of treating sexual disturbances |
| 07/13/2000 | WO2000040225A2 Inhibition of tnf activity |
| 07/13/2000 | WO2000040220A1 Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same |
| 07/13/2000 | WO2000040219A1 Dispersible concentrate for the delivery of cyclosporin |
| 07/13/2000 | WO2000040215A1 Cosmetic or dermatological composition containing an active principle stimulating hsp 32 protein synthesis in the skin and cosmetic treatment method |
| 07/13/2000 | WO2000040204A2 Methods for treating cystic fibrosis |
| 07/13/2000 | WO2000040089A1 Targeted transscleral controlled release drug delivery to the retina and choroid |
| 07/13/2000 | WO2000040086A1 Formulations for treating disease and methods of using same |
| 07/13/2000 | WO2000027363B1 Aerosols comprising nanoparticle drugs |
| 07/13/2000 | WO2000026242A9 Dna replication-regulating genes, antibodies thereto and diagnostic applications thereof |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000023091A3 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 07/13/2000 | WO2000022118A3 Non-desensitizing ampa-receptors |
| 07/13/2000 | WO2000021987A3 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 07/13/2000 | WO2000021986A3 Matrix-remodeling genes |